Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).

Share Your Research with the Respiratory Disease Community at ATS 2024 in San Diego

The American Thoracic Society is accepting scientific abstracts and case report submissions for presentation at the ATS 2024 International Conference in San Diego, May 17-22. Submissions on all aspects of respiratory disease, critical care medicine and sleep medicine will be considered and are due no later than Wednesday, Nov. 1, 2023, at 5 p.m. ET.

Save the Date! Washington, DC to Host ATS 2023

It has been six years since the ATS International Conference was last held in Washington, DC, and the world has changed dramatically. We are excited to welcome you back to the nation’s capital for ATS 2023, when we will engage leaders, as well as emerging scientists and clinicians, in passionate discussions of medical breakthroughs and clinical innovation to meet the needs of patients worldwide.

Computational Evaluation of Drug Delivery Reveals Room for Inhalers Improvement

Increased air pollution in recent years has exacerbated health risks for people who suffer from pulmonary diseases and these dynamics underscore the importance of increasing the efficacy of drug delivery devices that administer active pharmaceutical ingredients to treat respiratory illnesses. In Physics of Fluids, researchers describe developing a computational evaluation of drug delivery through both pressurized metered-dose inhalers and dry powder inhalers to determine how the process can be improved.

Mount Sinai’s Simulation Teaching and Research Center Earns Four Accreditations From Society for Simulation in Healthcare

Only center in the world with this combination of distinctions

University of Miami Health System Sarcoidosis Program Recognized as Center of Excellence

With its multidisciplinary approach to patient care, research and education, the University of Miami Sarcoidosis Program has been recognized as one of world’s leading centers for this complex multisystem disorder by the World Association of Sarcoidosis and Other Granulomatous Diseases/Foundation of Sarcoidosis Research (WASOG-FSR).

University of Miami Health System researchers publish overview of evidence that COVID-19’s impact affects much more than the lungs

Studies suggest COVID-19 patients may at first present with atypical neurologic, gastrointestinal, cardiac and musculoskeletal imaging findings, which are more likely to go undiagnosed, according to the paper “Clinical Characteristics and Multisystem Imaging Findings of COVID-19: An Overview for Orthopedic Surgeons,” published August 17 in HHS Journal: the musculoskeletal journal of Hospital for Special Surgery.

Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19

A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.

Mount Sinai Study Finds COVID-19 May Be Driven by Pulmonary Thrombi and Pulmonary Endothelial Dysfunction

A new study from the Icahn School of Medicine at Mount Sinai suggests that blood clots, especially in the lungs, may play a role in severe cases of COVID-19.

Following the lizard lung labyrinth

Mammals inhale oxygen-rich air and they exhale depleted air, exhibiting a so-called tidal flow pattern. In contrast, bird breath travels through part of the respiratory system, but in a one-way loop throughout most of the lung. Biologists have discovered that Savannah monitor lizards have lung structures that are hybrid system of bird and mammal lungs.

What You Need to Know About Vaping-Associated Lung Injury

Vaping-associated lung injury is a condition characterized by lung inflammation and damage that can lead to respiratory failure and death. Symptoms include shortness of breath, cough, and chest pain, as well as fatigue, fever, and weight loss. Many patients report gastrointestinal symptoms too.

Healthcare experts are urging people to avoid vaping because the exact cause of vaping-associated lung injury is unknown.

People who are using vaping products — especially young people, who have been most frequently affected by the condition — should closely monitor their health and seek immediate medical care if they develop symptoms.